{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:34:58Z","timestamp":1785764098539,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470231"],"award-info":[{"award-number":["82470231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270237"],"award-info":[{"award-number":["82270237"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2025A03J3453"],"award-info":[{"award-number":["2025A03J3453"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2024A03J0079"],"award-info":[{"award-number":["2024A03J0079"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2025A03J3369"],"award-info":[{"award-number":["2025A03J3369"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010924"],"award-info":[{"award-number":["2023A1515010924"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515010465"],"award-info":[{"award-number":["2025A1515010465"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejphar.2025.178478","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:43:18Z","timestamp":1765611798000},"page":"178478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synergistic effects between CD36 monoclonal antibody and cytarabine for treatment of AML"],"prefix":"10.1016","volume":"1012","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0634-4870","authenticated-orcid":false,"given":"Shuxin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunte","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sentot","family":"Santoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2199-2980","authenticated-orcid":false,"given":"Yongshui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ejphar.2025.178478_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ejphar.2025.178478_bib2","article-title":"Resistance mechanism of acute myeloid leukemia cells against daunorubicin and cytarabine: a literature review","volume":"14","author":"Arwanih","year":"2022","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.ejphar.2025.178478_bib3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-021-00264-y","article-title":"Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia","volume":"2","author":"Bosc","year":"2021","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3324\/haematol.2017.176248","article-title":"Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents","volume":"103","author":"Cagnetta","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2191302","article-title":"Impact of IgG subclass on monoclonal antibody developability","volume":"15","author":"Cain","year":"2023","journal-title":"MAbs"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178478_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165142","article-title":"Mechanism and intervention of murine transfusion-related acute lung injury caused by anti-CD36 antibodies","volume":"8","author":"Chen","year":"2023","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178478_bib7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.2024028012","article-title":"Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI","volume":"146","author":"Chen","year":"2025","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178478_bib8","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"issue":"41","key":"10.1016\/j.ejphar.2025.178478_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi8534","article-title":"Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model","volume":"9","author":"Choi","year":"2023","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.ejphar.2025.178478_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.ejphar.2025.178478_bib11","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1158\/0008-5472.CAN-22-3682","article-title":"CD36 drives metastasis and relapse in acute myeloid leukemia","volume":"83","author":"Farge","year":"2023","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ejphar.2025.178478_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jlb.49.6.556","article-title":"The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc gamma RII","volume":"49","author":"Fleit","year":"1991","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2025.178478_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cellimm.2018.07.008","article-title":"Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens","volume":"332","author":"Forrester","year":"2018","journal-title":"Cell. Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.178478_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00011.2023","article-title":"CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease","volume":"104","author":"Glatz","year":"2024","journal-title":"Physiol. Rev."},{"issue":"16","key":"10.1016\/j.ejphar.2025.178478_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168947","article-title":"The role of Fc receptors on the effectiveness of therapeutic monoclonal antibodies","volume":"22","author":"Gogesch","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2025.178478_bib16","article-title":"A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML","volume":"5","author":"Guo","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejphar.2025.178478_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.coph.2018.05.010","article-title":"Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases","volume":"41","author":"Hafeez","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.178478_bib18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1158\/1078-0432.CCR-20-2149","article-title":"Development of highly optimized antibody-drug conjugates against CD33 and CD123 for acute myeloid leukemia","volume":"27","author":"Han","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178478_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biomaterials.2015.07.012","article-title":"Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity","volume":"67","author":"Hong","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejphar.2025.178478_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177163","article-title":"Inhibition of TOX exerts anti-tumor effects in acute myeloid leukemia by upregulating IRF7 expression","volume":"987","author":"Huang","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","article-title":"Current status and research directions in acute myeloid leukemia","volume":"14","author":"Kantarjian","year":"2024","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.ejphar.2025.178478_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood.V64.1.54.54","article-title":"Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cells","volume":"64","author":"Kufe","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2025.178478_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101193","article-title":"CD36 favours fat sensing and transport to govern lipid metabolism","volume":"88","author":"Li","year":"2022","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"9","key":"10.1016\/j.ejphar.2025.178478_bib26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3324\/haematol.2010.031823","article-title":"ATP binding cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients","volume":"96","author":"Marzac","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s11658-023-00455-8","article-title":"Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment","volume":"28","author":"Meng","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178478_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1158\/2643-3230.BCD-23-0202","article-title":"Recent advances in immune-based therapies for acute myeloid leukemia","volume":"5","author":"Restelli","year":"2024","journal-title":"Blood Cancer Discov."},{"issue":"9","key":"10.1016\/j.ejphar.2025.178478_bib29","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1016\/S2352-3026(23)00159-X","article-title":"Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts","volume":"10","author":"Shallis","year":"2023","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ejphar.2025.178478_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","article-title":"The role of CD36 in cardiovascular disease","volume":"118","author":"Shu","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178478_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2020.08.015","article-title":"Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: antibody deglycosylation only eliminates IgG2b binding","volume":"127","author":"Temming","year":"2020","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.2023022481","article-title":"How I treat refractory and relapsed acute myeloid leukemia","volume":"143","author":"Thol","year":"2024","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.ejphar.2025.178478_bib34","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1158\/0008-5472.CAN-21-1109","article-title":"Mechanisms of therapeutic antitumor monoclonal antibodies","volume":"81","author":"Tsao","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib35","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/imr.13394","article-title":"Enhancing Fc-mediated effector functions of monoclonal antibodies: the example of HexaBodies","volume":"328","author":"van der Horst","year":"2024","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.ejphar.2025.178478_bib36","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3892\/ijo_00000446","article-title":"Dysregulation of the cell survival\/anti-apoptotic NF-kappaB pathway by the novel humanized BM-ca anti-CD20 mAb: implication in chemosensitization","volume":"35","author":"Vega","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"23","key":"10.1016\/j.ejphar.2025.178478_bib37","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1158\/1078-0432.CCR-21-2040","article-title":"Single-cell profiling reveals metabolic reprogramming as a resistance mechanism in BRAF-mutated multiple myeloma","volume":"27","author":"Waldschmidt","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178478_bib38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","article-title":"CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors","volume":"21","author":"Wang","year":"2020","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178478_bib39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000513696","article-title":"Deoxycytidine kinase (DCK) mutations in human acute myeloid leukemia resistant to cytarabine","volume":"144","author":"Wu","year":"2021","journal-title":"Acta Haematol."},{"key":"10.1016\/j.ejphar.2025.178478_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115834","article-title":"Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance","volume":"168","author":"Xia","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"18","key":"10.1016\/j.ejphar.2025.178478_bib41","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood.2021011131","article-title":"Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model","volume":"138","author":"Xu","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ejphar.2025.178478_bib42","first-page":"918","article-title":"Preparation and preliminary identification of Fc-silent anti-human CD36 chimeric antibody","volume":"40","author":"Xu","year":"2024","journal-title":"Chinese J. Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2025.178478_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155905","article-title":"Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression","volume":"155","author":"Yang","year":"2024","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41419-025-07653-6","article-title":"Mechanisms of chemotherapy failure in refractory\/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolism","volume":"16","author":"Yeon Chae","year":"2025","journal-title":"Cell Death Dis."},{"issue":"21","key":"10.1016\/j.ejphar.2025.178478_bib45","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1158\/1078-0432.CCR-19-0187","article-title":"Anticancer immunotherapy by MFAP5 blockade inhibits fibrosis and enhances chemosensitivity in ovarian and pancreatic cancer","volume":"25","author":"Yeung","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ejphar.2025.178478_bib46","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1182\/bloodadvances.2022008344","article-title":"Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma","volume":"7","author":"Younes","year":"2023","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178478_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113112","article-title":"IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia","volume":"415","author":"Zhang","year":"2022","journal-title":"Exp. Cell Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925012324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925012324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:59:41Z","timestamp":1777402781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925012324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S0014299925012324"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178478","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effects between CD36 monoclonal antibody and cytarabine for treatment of AML","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178478"}}